financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Lowers Opinion On Shares Of Foot Locker To Strong Sell From Sell
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Lowers Opinion On Shares Of Foot Locker To Strong Sell From Sell
Mar 6, 2024 5:21 AM

08:10 AM EST, 03/06/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We raise our 12-month price target by $3 to $18, based on 10.3x our FY 25 (Jan.) EPS estimate and in line with the company's 5-year average forward P/E multiple of 10.1x. We lower our FY 25 EPS estimate by $0.25 to $1.75 and initiate our FY 26 EPS estimate at $2.00. FL posts normalized Q4 EPS of $0.38 vs. $0.97, $0.06 above consensus estimates on revenues of $2.38B vs. $2.33B and $105M above estimates. Q4 gross margin compressed 350 bps Y/Y due to higher markdowns, while SG&A remained flat as a percentage of sales. During Q4, FL opened 29 stores and closed 113 stores. FL expects flat sales in FY 25 with non-GAAP EPS between $1.50 and $1.70. FL also plans to close 4% of its stores in the new fiscal year. We believe valuation is now extreme after shares have doubled since October and now trade at 18x the upper end of its full year guidance and well above its 5-year average forward P/E multiple. FL has not proven it can grow top or bottom line consistently in this new retail environment of direct-to-consumer.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Reiterates Buy Opinion On Shares Of Visteon Corporation
Research Alert: CFRA Reiterates Buy Opinion On Shares Of Visteon Corporation
Oct 23, 2025
11:20 AM EDT, 10/23/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We maintain a 12-month target of $135, based on a 2026 P/E of 14.0x, a steep discount to historic averages. We maintain our adjusted EPS estimates of $9.20 for 2025...
Research Alert: CFRA Retains Sell Opinion On Shares Of Molina Healthcare, Inc.
Research Alert: CFRA Retains Sell Opinion On Shares Of Molina Healthcare, Inc.
Oct 23, 2025
11:20 AM EDT, 10/23/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: Molina Healthcare ( MOH ) reported disappointing Q3 2025 results, with adjusted EPS of $1.84 falling significantly short of the $3.89 consensus estimate and declining 69% Y/Y due to elevated...
Research Alert: CFRA Keeps Hold Opinion On Shares Of Cbre Group, Inc.
Research Alert: CFRA Keeps Hold Opinion On Shares Of Cbre Group, Inc.
Oct 23, 2025
12:50 PM EDT, 10/23/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We increase our target by $20 to $180, applying a forward P/E of 25.1x our 2026 EPS estimate, a premium to CBRE's ( CBRE ) three-year average multiple (20.8x), as...
Research Alert: CFRA Reiterates Strong Buy Opinion On Shares Of Autonation, Inc.
Research Alert: CFRA Reiterates Strong Buy Opinion On Shares Of Autonation, Inc.
Oct 23, 2025
12:55 PM EDT, 10/23/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our 12-month target by $15 to $255, based on a 2026 P/E of 11.5x, a premium to historic averages justified by market conditions we consider early-cycle. We increase...
Copyright 2023-2026 - www.financetom.com All Rights Reserved